Nexotype

Nexotype is a biotech intelligence and drug discovery platform built around a source-attributed knowledge graph that connects genomics, pipelines, and commercial data. It is described as a single system for drug discovery, pipeline tracking, and market intelligence, with a focus on tracing information from genes through revenue.

Its feature set includes genomic analysis for uploading genetic data, detecting variants, and generating genotype-aware health insights. The platform also offers biomarker tracking from wearables, labs, and manual entry with unit standardization, drug discovery management across small molecules, biologics, peptides, and oligonucleotides, and a knowledge graph linking drug-target mechanisms, bioactivities, and therapeutic efficacies to evidence sources. Other named functions include LIMS integration for subject management, biospecimen tracking, assay protocols, and quantitative readouts, plus commercial intelligence covering company deep dives, mergers and acquisitions, licensing deals, patents, revenue lines, and patent-cliff math. It also supports development pipeline monitoring, market organizations, technology platforms, and evidence-backed treatment suggestions based on genomic profile and biomarker data.

The product is presented as a deterministic query engine over a curated biomedical knowledge graph rather than a chatbot. It supports question answering in plain English and lists seven query tools: company portfolios, drug discovery paths, competitive landscapes, entity networks, pathway exploration, literature search, and variant analysis. Answers are traceable to PubMed, ClinicalTrials.gov, DrugBank, and patent databases, with source attribution and confidence scores. The site also says it is MCP-native and offers an MCP integration so the graph can be queried from external AI tools, with a dashboard and an Open Dashboard link shown on the page.

Nexotype names biotech teams, investors, researchers, and doctors among its use cases, and shows examples for company pipeline intelligence, investor or VC market intelligence, and scientific discovery. The page includes a pricing navigation item but does not state a price or license. It also highlights counts for biomedical entities, companies, genes, pathways, and ontology terms, though those are presented as current platform figures rather than product capabilities.